Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Taihe Pharmaceutical is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) and chemical intermediates based in Zibo, China. Established in 1992, the company has grown into a significant global supplier of non-steroidal anti-inflammatory drugs (NSAIDs), including Ibuprofen and Naproxen, as well as gastrointestinal and antibacterial agents. The company operates large-scale, GMP-compliant production facilities and exports its products to over 30 countries, serving major pharmaceutical markets in Europe and North America. Beyond its core product portfolio, Shandong Taihe Pharmaceutical offers contract manufacturing services (CMO) for custom synthesis and process development. Its strategic focus remains on high-quality, high-volume production of essential generic drug components.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Taihe Pharmaceutical Technology.